CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+7.34%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$6.59B
AUM Growth
+$6.59B
(+12%)
Cap. Flow
+$266M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
67.98%
Holding
142
New
14
Increased
47
Reduced
57
Closed
13
Top Buys
| 1 |
Visa
V
|
$48M |
| 2 |
Microsoft
MSFT
|
$42.7M |
| 3 |
Thermo Fisher Scientific
TMO
|
$38.8M |
| 4 |
Ecolab
ECL
|
$37.9M |
| 5 |
FRC
First Republic Bank
FRC
|
$34.6M |
Top Sells
| 1 |
HDFC Bank
HDB
|
$105M |
| 2 |
Philip Morris
PM
|
$21.5M |
| 3 |
Meta Platforms (Facebook)
META
|
$11.6M |
| 4 |
CELG
Celgene Corp
CELG
|
$10.4M |
| 5 |
Merck
MRK
|
$8.98M |
Sector Composition
| 1 | Financials | 26.2% |
| 2 | Healthcare | 18.75% |
| 3 | Consumer Discretionary | 17.75% |
| 4 | Communication Services | 14.57% |
| 5 | Materials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola
KO
$296B
| $36.2M | 0.55% |
806,708
+520,720
| +182% | +$23.4M |
|
|
AGN
27
DELISTED
Allergan plc
AGN
| $24M | 0.36% |
98,790
-9,806
| -9% | -$2.38M |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $23.9M | 0.36% |
184,063
-79,796
| -30% | -$10.4M |
|
|
CLVS
29
DELISTED
Clovis Oncology, Inc.
CLVS
| $20.9M | 0.32% |
223,560
-85,609
| -28% | -$8.02M |
|
30
Amgen
AMGN
$153B
| $19.8M | 0.3% |
115,228
-39,526
| -26% | -$6.81M |
|
31
Pfizer
PFE
$141B
| $19.2M | 0.29% |
570,202
-188,509
| -25% | -$6.33M |
|
32
Biogen
BIIB
$21B
| $17.7M | 0.27% |
65,375
-18,758
| -22% | -$5.09M |
|
33
Jazz Pharmaceuticals
JAZZ
$7.96B
| $16.3M | 0.25% |
105,048
+6,583
| +7% | +$1.02M |
|
34
Centene
CNC
$14.5B
| $16.3M | 0.25% |
203,544
-49,126
| -19% | -$3.92M |
|
35
Cigna
CI
$79.8B
| $16.2M | 0.25% |
96,878
-24,850
| -20% | -$4.16M |
|
36
Incyte
INCY
$17B
| $15.6M | 0.24% |
123,724
-13,844
| -10% | -$1.74M |
|
37
Bristol-Myers Squibb
BMY
$97.1B
| $14.9M | 0.23% |
+267,012
| New | +$14.9M |
|
|
ALXN
38
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $13.8M | 0.21% |
113,427
+74,676
| +193% | +$9.09M |
|
|
39
Merck
MRK
$213B
| $13.3M | 0.2% |
208,069
-140,131
| -40% | -$8.98M |
|
40
AbbVie
ABBV
$375B
| $12.4M | 0.19% |
171,047
+90,222
| +112% | +$6.54M |
|
41
Alphabet (Google) Class A
GOOGL
$2.77T
| $12.1M | 0.18% |
13,054
| – | – |
|
|
SHPG
42
DELISTED
Shire pic
SHPG
| $11.9M | 0.18% |
71,845
-42,955
| -37% | -$7.1M |
|
43
HCA Healthcare
HCA
$95B
| $11.9M | 0.18% |
136,152
-12,733
| -9% | -$1.11M |
|
44
Edwards Lifesciences
EW
$48B
| $11.4M | 0.17% |
96,262
-9,466
| -9% | -$1.12M |
|
45
Nike
NKE
$110B
| $11.2M | 0.17% |
190,523
-6,969
| -4% | -$411K |
|
46
Eli Lilly
LLY
$660B
| $10.7M | 0.16% |
130,484
-13,511
| -9% | -$1.11M |
|
47
Glaukos
GKOS
$5.4B
| $10.7M | 0.16% |
257,831
-102,977
| -29% | -$4.27M |
|
|
PRTK
48
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $10.6M | 0.16% |
439,400
+359,400
| +449% | +$8.66M |
|
49
Boston Scientific
BSX
$159B
| $10.6M | 0.16% |
+381,472
| New | +$10.6M |
|
50
BioMarin Pharmaceuticals
BMRN
$11.3B
| $9.43M | 0.14% |
103,781
-60,704
| -37% | -$5.51M |
|